Beam Therapeutics Inc
BEAM
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.47B
Close$
$-25.93
208.1% downside
Current Fair Value
208.1% downsideOvervalued by 208.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.47 Billion |
|---|---|
| Enterprise Value | $2.50 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.81 |
| Beta | 2.23 |
| Outstanding Shares | 104,326,669 |
Return
| Return on Equity | -8.00% |
|---|---|
| Return on Assets | -6.16% |
| Return on Invested Capital | -8.39% |
Valuation & Multiples
| P/E Ratio | -29.26 |
|---|---|
| PEG | -146.79 |
| Price to Sales | 23.99 |
| Price to Book Ratio | 2.4 |
| Enterprise Value to Revenue | 20.08 |
| Enterprise Value to EBIT | -22.79 |
| Enterprise Value to Net Income | -30 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-1.09
Average shareholder expectationRevenue Estimate
$13.85 M
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$-1.16
Average shareholder expectationRevenue Estimate
$8.75 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3294▼ 19.51% |
|---|---|
| Total Calls | 588,900▲ 1.27% |
| Total Puts | 194,000▼ 36.39% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 109.04%▲ 4.18% |
|---|---|
| Total Invested | $3.88B▲ 50.63% |
| Investors Holding | 286▲ 21.00% |
ESG Score
No data